Treatment of Muscle Injury Following Arthroplasty for Hip Fracture (HF)
Aging | Diseases of the Musculoskeletal System
What is the purpose of this trial?
The objectives of this study are to assess the efficacy, safety, and tolerability of PLX-PAD intramuscular administration for the treatment of muscle injury following arthroplasty for HF.
- Ages60 - 90 years
- Trial withPluristem Ltd.
- Start Date09/21/2018
- End Date06/30/2020
- Last Updated01/17/2019
- Study HIC#2000023630